assessment after diagnosis

Last edited 02/2018 and last reviewed 06/2021

Determining suitability for radical treatment of histologically-confirmed oesophageal or gastro-oesophageal junctional cancer after endoscopy and wholebody CT scan diagnosis

• F-18 FDG PET-CT should be offered to people with oesophageal and gastro-oesophageal junctional tumours that are suitable for radical treatment (except for T1a tumours)
  
  
• do not offer endoscopic ultrasound only to distinguish between T2-T3 tumours in people with oesophageal and gastro-oesophageal junctional tumours
  
  
• endoscopic ultrasound should only be offered to people with oesophageal and gastrooesophageal junctional cancer when it will help guide ongoing management
  
  
• staging laparoscopy should only considered for people with oesophageal or gastrooesophageal junctional cancer when it will help guide ongoing management.

HER2 testing in metastatic oesophago-gastric adenocarcinoma

• HER2 testing should be offered to people with metastatic oesophago-gastric adenocarcinoma

Reference:

• NICE (January 2018). Oesophago-gastric cancer: assessment and management in adults